Pharmacotherapy Home

Pharmacotherapy

Faculty

Photo

Kuhn, John G., Pharm.D.
Emeritus Professor
of Pharmacotherapy
210- 567-8340
kuhn@uthscsa.edu


Summary & Research Interests

The research in our laboratories is concentrated on deriving information related to the clinical pharmacology of anticancer agents.  To accomplish our research objectives, we establish suitable analytical (HPLC, CE, LC/MS) or molecular (PCR, Western, Elisa) methods for the measurement of the compounds in biological fluids or tissue.  We explore the relationships between the pharmacokinetic parameters (clearance, AUC) of the agent and their biological targets, activity and/or toxicity.  These correlations permit the development of rational dosing and scheduling regimens for the optimization of the compound's therapeutic index.     We also evaluate genetic variations responsible for drug metabolism, transport or target affinity.  The laboratories serve as the Pharmacology Core for the North American Brain Tumor Consortium (NABTC).


illustration


More information about Dr. Kuhn
> Selected Publications

Last Reviewed: September 18, 2008

Division Information

Mailing Address:
Pharmacotherapy
Education & Research Ctr.
College of Pharmacy
The University of Texas
Health Science Center
7703 Floyd Curl Drive - MC 6220
San Antonio, TX
78229-3900
USA

Email Address: pharmacy
@austin.utexas.edu

Phone:
1-210-567-8355


Reveles Traces Rate of Hospital Infections

Dr. Kelly Reveles, assistant professor of pharmacotherapy, is primary author of a study which found that the incidence of Clostridium difficile infection (CDI), a highly contagious gastrointestinal disease often linked to the overprescribing of antibiotics, nearly doubled between 2001 and 2010. It also determined there were no improvements in patient health outcomes, including mortality or hospital length of stay, over the study period.

Read more about Reveles' study.

index of the major headings: a b c d e f g h i j k l m n o p q r s t u v w x y z